PMID- 20980457 OWN - NLM STAT- MEDLINE DCOM- 20110310 LR - 20220321 IS - 1939-327X (Electronic) IS - 0012-1797 (Print) IS - 0012-1797 (Linking) VI - 60 IP - 2 DP - 2011 Feb TI - The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. PG - 590-601 LID - 10.2337/db10-0403 [doi] AB - OBJECTIVE: Although Smad3 has been considered as a downstream mediator of transforming growth factor-beta (TGF-beta) signaling in diabetes complications, the role of Smad7 in diabetes remains largely unclear. The current study tests the hypothesis that Smad7 may play a protective role and has therapeutic potential for diabetic kidney disease. RESEARCH DESIGN AND METHODS: Protective role of Smad7 in diabetic kidney disease was examined in streptozotocin-induced diabetic mice that have Smad7 gene knockout (KO) and in diabetic rats given Smad7 gene transfer using an ultrasound-microbubble-mediated technique. RESULTS: We found that mice deficient for Smad7 developed more severe diabetic kidney injury than wild-type mice as evidenced by a significant increase in microalbuminuria, renal fibrosis (collagen I, IV, and fibronectin), and renal inflammation (interleukin-1beta [IL-1beta], tumor necrosis factor-alpha [TNF-alpha], monocyte chemoattractant protein-1 [MCP-1], intracellular adhesion molecule-1 [ICAM-1], and macrophages). Further studies revealed that enhanced renal fibrosis and inflammation in Smad7 KO mice with diabetes were associated with increased activation of both TGF-beta/Smad2/3 and nuclear factor-kappaB (NF-kappaB) signaling pathways. To develop a therapeutic potential for diabetic kidney disease, Smad7 gene was transferred into the kidney in diabetic rats by an ultrasound-microbubble-mediated technique. Although overexpression of renal Smad7 had no effect on levels of blood glucose, it significantly attenuated the development of microalbuminuria, TGF-beta/Smad3-mediated renal fibrosis such as collagen I and IV and fibronectin accumulation and NF-kappaB/p65-driven renal inflammation including IL-1beta, TNF-alpha, MCP-1, and ICAM-1 expression and macrophage infiltration in diabetic rats. CONCLUSIONS: Smad7 plays a protective role in diabetic renal injury. Overexpression of Smad7 may represent a novel therapy for the diabetic kidney complication. FAU - Chen, Hai Yong AU - Chen HY AD - Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China. FAU - Huang, Xiao R AU - Huang XR FAU - Wang, Wansheng AU - Wang W FAU - Li, Jin Hua AU - Li JH FAU - Heuchel, Rainer L AU - Heuchel RL FAU - Chung, Arthur C K AU - Chung AC FAU - Lan, Hui Yao AU - Lan HY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101027 PL - United States TA - Diabetes JT - Diabetes JID - 0372763 RN - 0 (Blood Glucose) RN - 0 (Cytokines) RN - 0 (Smad7 Protein) SB - IM MH - Albuminuria/genetics/metabolism/pathology MH - Analysis of Variance MH - Animals MH - Blood Glucose MH - Blotting, Western MH - Cytokines/genetics/metabolism MH - Diabetes Mellitus, Experimental/genetics/*metabolism/pathology MH - Diabetic Nephropathies/genetics/*metabolism/pathology MH - Fibrosis/genetics/metabolism/pathology MH - Gene Transfer Techniques MH - Immunohistochemistry MH - Inflammation/genetics/metabolism/pathology MH - Kidney Glomerulus/*metabolism/pathology MH - Male MH - Mice MH - Mice, Knockout MH - Rats MH - Reverse Transcriptase Polymerase Chain Reaction MH - Signal Transduction MH - Smad7 Protein/genetics/*metabolism PMC - PMC3028360 EDAT- 2010/10/29 06:00 MHDA- 2011/03/11 06:00 PMCR- 2012/02/01 CRDT- 2010/10/29 06:00 PHST- 2010/10/29 06:00 [entrez] PHST- 2010/10/29 06:00 [pubmed] PHST- 2011/03/11 06:00 [medline] PHST- 2012/02/01 00:00 [pmc-release] AID - db10-0403 [pii] AID - 0403 [pii] AID - 10.2337/db10-0403 [doi] PST - ppublish SO - Diabetes. 2011 Feb;60(2):590-601. doi: 10.2337/db10-0403. Epub 2010 Oct 27.